市場調査レポート
商品コード
1069405
糖尿病治療機器の世界市場:現状分析と予測(2021年~2027年)Diabetes Care Devices Market: Current Analysis and Forecast (2021-2027) |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
糖尿病治療機器の世界市場:現状分析と予測(2021年~2027年) |
出版日: 2022年02月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 248 Pages
納期: 即日から翌営業日
|
世界の糖尿病治療機器の市場規模は、予測期間(2021年~2027年)に約6%のCAGRが見込まれています。
ヒト用インスリン送達システムの進歩、インスリン送達システム技術の革新、償還政策、糖尿病管理に関する国民の意識の高まりなどが、市場の成長を促進する要因となっています。
当レポートでは、世界の糖尿病治療機器市場について調査しており、市場要約、市場の洞察、市場機会、競合シナリオ、企業概要など、包括的な情報を提供しています。
Diabetes Care Devices Market is expected to grow at a CAGR of around 6% over the forecast period (2021-2027). The rise of this market is fueled by a growing diabetic population, obesity, and a sedentary lifestyle. Furthermore, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, as well as rising awareness among the population about diabetes control and accessibility to insulin delivery systems, are all factors ensuring the market's growth.
Several government organizations are focusing on boosting the existing infrastructure for overall healthcare system development. Among the countries worldwide, the United States had the highest percentage of gross domestic product spent on health care in 2019. The U.S. spent nearly 17% of its GDP on health care services. Germany, Switzerland, and France followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries.
The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.
Some of the major players operating in the market include: Medtronic, DexCom, Inc., F. Hoffmann-La Roche AG, Novo Nordisk A/S, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Tandem Diabetes are, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.
Insights Presented in the Report
"Amongst Type, Insulin Pens segment dominated the market in 2020"
Based on Type, the market is segmented into Devices (Self-monitoring Blood Glucose (Glucometer Devices, Test Strips, Lancets), Continuous Glucose Monitoring (Sensors, Durables), Management Devices [Insulin Pumps (Insulin Pump Device, Insulin Pump Reservoir), Infusion Set, Insulin Syringes, Insulin Cartridges, Disposable Pens, Jet Injectors. The Monitoring Devices segment leads the Diabetes Care Devices Market. Insulin pens are growing in popularity, and many people with diabetes nowadays use home-based glucose monitoring devices to keep check on their diabetes readings.
"Amongst End-User, Patients/Homecare segment dominated the market in 2020."
Based on End-User, the Diabetes Care Devices market is segmented into Patients/Homecare and Hospitals & Clinics. The patients/homecare segment commanded the largest share of the diabetes care devices market and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing diabetic population and rising healthcare expenditure.
"North America represents as the largest market."
For a better understanding of the market adoption of Diabetes Care Devices, the market is analyzed for the countries such as North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), & Rest of World. Asia-Pacific dominated the market in 2020. North America dominated the market. The rising prevalence of diabetes and favorable reimbursement scenario in the United States and Canada, growing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States all contribute to this region's large share.
Reasons to buy this report:
The study includes market sizing and forecasting analysis validated by authenticated key industry experts
The report presents a quick review of overall industry performance at one glance
The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
The study comprehensively covers the market across different segments
Deep dive regional & country-level analysis of the industry
Customization Options:
Diabetes Care Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.